INCRAFT支架系统经皮EVAR治疗破裂性腹主动脉瘤
本研究回顾性纳入2015至2019年单中心15例接受INCRAFT系统经皮EVAR治疗的破裂性腹主动脉瘤男性患者,平均年龄74岁,中位瘤径8.25 cm。装置全部成功释放,80.0%仅用局部麻醉完成,30天和1年死亡率分别为26.6%和33.3%,中位随访57个月长期生存率60.0%。
要点
- INCRAFT系统经皮EVAR治疗rAAA技术成功率高,装置全部成功释放。
- 80.0%患者仅局部麻醉即可完成手术,30天死亡率26.6%。
- 中位随访57个月长期生存率60.0%,2例因内漏需晚期再干预。
核心结论
- INCRAFT系统可经皮治疗破裂性腹主动脉瘤,技术成功率高,死亡率与其他装置文献报告相似。
- 绝大多数手术可仅用局部麻醉完成。
研究设计与样本
- 单中心回顾性研究,纳入2015至2019年所有接受INCRAFT系统经皮EVAR治疗的破裂性腹主动脉瘤患者。
- 共15例男性患者,平均年龄74岁(SD 6.7),中位动脉瘤直径8.25 cm(SD 1.66)。
主要发现
- 装置在所有患者中成功输送并释放。
- 术中1例I型内漏需追加支架置入,1例出现装置主体及髂支急性血栓需血栓清除。
- 80.0%患者仅用局部麻醉成功完成手术。
- 30天死亡率为26.6%,1年死亡率为33.3%。
- 中位随访57个月长期生存率60.0%,2例因内漏需晚期再干预。
临床怎么用
- INCRAFT系统可作为破裂性腹主动脉瘤经皮EVAR的治疗选择之一。
- 多数rAAA患者可考虑仅用局部麻醉完成EVAR,避免全身麻醉。
局限性
- 单中心回顾性设计,样本量小(15例),均为男性患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Low profile endovascular aneurysm repair (EVAR) devices such as the Cordis INCRAFT AAA Stent Graft System may expand the category of patients suitable for endovascular repair. We report our experience with the INCRAFT system in treating ruptured abdominal aortic aneurysms (rAAA). METHODS: We included all patients presenting with rAAA from 2015 to 2019 in our hospital who were treated by percutaneous EVAR with the INCRAFT system. The primary outcome was technical success, referring to adequate stent graft placement. Secondary outcomes included completion of the procedure under local anesthesia and mortality at 30-days, one year and long-term follow-up. RESULTS: Fifteen male patients (mean age: 74 years, SD 6.7) were treated for rAAA with a median aneurysm diameter of 8.25 cm (SD 1.66). The device was successfully delivered and deployed in all subjects. Per-procedurally one type I endoleak required additional stent placement and one patient developed an acute thrombosis of the device main body and iliac limbs requiring thrombectomy. 80.0% of patients were successfully treated under local anesthesia only. The 30 day and one year mortality were 26.6% and 33.3% respectively. Long-term survival was 60.0% at a median follow-up period of 57 months, with two patients requiring late reintervention for an endoleak. CONCLUSIONS: The INCRAFT system can be used to percutaneously treat rAAA with a high technical success rate and mortality similar to reported in the literature for other devices. The large majority of procedures can be completed with only local anesthesia.
引用
- Stomp W, Dierikx JE, Wever JJ, et al. Percutaneous EVAR for Ruptured Abdominal Aortic Aneurysms Using the Cordis INCRAFT Endograft. Ann Vasc Surg. 2021. PMID: 34644640. doi:10.1016/j.avsg.2021.07.018
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。